{"id":233852,"date":"2025-12-22T00:00:00","date_gmt":"2025-12-22T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041141-medtech-neurovascular-devices-market-insights-united\/"},"modified":"2026-03-31T10:09:19","modified_gmt":"2026-03-31T10:09:19","slug":"47042549-medtech-neurovascular-devices-market-insights-united-states","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042549-medtech-neurovascular-devices-market-insights-united-states\/","title":{"rendered":"Neurovascular Devices &#8211; Market Insights &#8211; United States"},"content":{"rendered":"<p>The US neurovascular device market will be fueled by high adoption of thrombectomy for <abbr data-abbreviation-entity=\"9251\" title=\"Acute Ischemic Stroke\">AIS<\/abbr> management, and the launch of new devices supported by strong clinical data.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for neurovascular devices in the US from 2019 through 2034.<\/p>\n<p class=\"question-statement\"><strong>Strong clinical evidence and new devices are driving adoption of neurovascular thrombectomy procedures.<\/strong><\/p>\n<p>What impact are recent clinical data having on thrombectomy device use and adoption?<\/p>\n<p>In which ways do emerging devices improve on previous offerings?<\/p>\n<p>For which indications have thrombectomy products been approved?<\/p>\n<p><strong>Embolization represents an emerging treatment for chronic subdural hematomas.<\/strong><\/p>\n<p>What new embolization products and companies are entering this market segment?<\/p>\n<p>How strongly are embolization products being adopted for this indication? What is the future adoption outlook?<\/p>\n<p>Which factors affect the decision to choose this emerging treatment?<\/p>\n<p class=\"question-statement\"><strong>Flow-diverting devices and liquid embolics are key drivers of growth in the neurovascular embolization device market. Their increasing use is enhancing treatment options and expanding the market.<\/strong><\/p>\n<p>How will adoption of flow-diverting devices impact the neurovascular embolization coil and coiling-assist device markets?<\/p>\n<p>How has the competitive landscape changed with the emergence of new competitors and products?<\/p>\n","protected":false},"template":"","class_list":["post-233852","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-geography-united-states","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":3,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233852\/revisions"}],"predecessor-version":[{"id":571868,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233852\/revisions\/571868"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=233852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}